Biomarkers in saliva for the detection of oral squamous cell carcinoma and their potential use for early diagnosis: a systematic review

References

• Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
   PubMed Web of Science ®Google Scholar
• Mishra R. Biomarkers of oral premalignant epithelial lesions for clinical application. Oral Oncol. 2012;48:578–584.
   PubMed Web of Science ®Google Scholar
• van der Waal I, de Bree R, Brakenhoff R, et al. Early diagnosis in primary oral cancer: is it possible? Med Oral Patol Oral Cir Bucal. 2011;16:e300–305.
   PubMed Web of Science ®Google Scholar
• Wu RQ, Zhao XF, Wang ZY, et al. Novel molecular events in oral carcinogenesis via integrative approaches. J Dent Res. 2011;90:561–572.
   PubMed Web of Science ®Google Scholar
• Groome PA, Rohland SL, Hall SF, et al. A population-based study of factors associated with early versus late stage oral cavity cancer diagnoses. Oral Oncol. 2011;47:642–647.
   PubMed Web of Science ®Google Scholar
• Peacock ZS, Pogrel MA, Schmidt BL. Exploring the reasons for delay in treatment of oral cancer. J Am Dent Assoc. 2008;139:1346–1352.
   PubMed Web of Science ®Google Scholar
• Rogers SN, Pabla R, McSorley A, et al. An assessment of deprivation as a factor in the delays in presentation, diagnosis and treatment in patients with oral and oropharyngeal squamous cell carcinoma. Oral Oncol. 2007;43:648–655.
   PubMed Web of Science ®Google Scholar
• Bohle G. Oral cancer update 2012. Be ever vigilant in diagnosis and early detection. J Okla Dent Assoc. 2012;103:34–36.
   PubMedGoogle Scholar
• Mehrotra R, Gupta DK. Exciting new advances in oral cancer diagnosis: avenues to early detection. Head Neck Oncol. 2011;3:33
   PubMedGoogle Scholar
• Diniz-Freitas M, Garcia-Garcia A, Crespo-Abelleira A, et al. Applications of exfoliative cytology in the diagnosis of oral cancer. Med Oral. 2004;9:355–361.
   PubMedGoogle Scholar
• Shah FD, Begum R, Vajaria BN, et al. A review on salivary genomics and proteomics biomarkers in oral cancer. Indian J Clin Biochem. 2011;26:326–334.
   PubMedGoogle Scholar
• Nagler RM. Saliva as a tool for oral cancer diagnosis and prognosis. Oral Oncol. 2009;45:1006–1010.
   PubMed Web of Science ®Google Scholar
• Liu J, Duan Y. Saliva: a potential media for disease diagnostics and monitoring. Oral Oncol. 2012;48:569–577.
   PubMed Web of Science ®Google Scholar
• Wu JY, Yi C, Chung HR, et al. Potential biomarkers in saliva for oral squamous cell carcinoma. Oral Oncol. 2010;46:226–231.
   PubMed Web of Science ®Google Scholar
• Brinkman BM, Wong DT. Disease mechanism and biomarkers of oral squamous cell carcinoma. Curr Opin Oncol. 2006;18:228–233.
   PubMed Web of Science ®Google Scholar
• Yakob M, Fuentes L, Wang MB, et al. Salivary biomarkers for detection of oral squamous cell carcinoma – current state and recent advances. Curr Oral Health Rep. 2014;1:133–141.
   PubMedGoogle Scholar
• Elashoff D, Zhou H, Reiss J, et al. Prevalidation of salivary biomarkers for oral cancer detection. Cancer Epidemiol Biomarkers Prev. 2012;21:664–672.
   PubMed Web of Science ®Google Scholar
• Prasad G, McCullough M. Chemokines and cytokines as salivary biomarkers for the early diagnosis of oral cancer. Int J Dent. 2013;2013:813756.
   PubMedGoogle Scholar
• Jou YJ, Lin CD, Lai CH, et al. Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer. Anal Chim Acta. 2010;681:41–48.
   PubMed Web of Science ®Google Scholar
• Sharma M, Bairy I, Pai K, et al. Salivary IL6 levels in oral leukoplakia with dysplasia andits clinical relevance to tobacco habits andperiodontitis. Clin Oral Investig. 2011;15:705–714.
   PubMed Web of Science ®Google Scholar
• Cheng YS, Rees T, Jordan L, et al. Salivary endothelin-1 potential for detecting oral cancer in patients with oral lichen planus or oral cancer in remission. Oral Oncol. 2011;47:1122–1126.
   PubMed Web of Science ®Google Scholar
• Hoffmann RR, Yurgel LS, Campos MM. Evaluation of salivary endothelin-1 levels in oral squamous cell carcinoma and oral leukoplakia. Regul Pept. 2011;166:55–58.
   PubMed Web of Science ®Google Scholar
• Franzmann EJ, Reategui EP, Pedroso F, et al. Soluble CD44 is a potential marker for the early detection of head and neck cancer. Cancer Epidemiol Biomarkers Prev. 2007;16:1348–1355.
   PubMed Web of Science ®Google Scholar
• Park NJ, Zhou H, Elashoff D, et al. Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res. 2009;15:5473–5477.
   PubMed Web of Science ®Google Scholar
• Pereira LH, Adebisi IN, Perez A, et al. Salivary markers and risk factor data: a multivariate modeling approach for head and neck squamous cell carcinoma detection. Cancer Biomark. 2011;10:241–249.
   PubMed Web of Science ®Google Scholar
• Hu S, Arellano M, Boontheung P, et al. Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res. 2008;14:6246–6252.
   PubMed Web of Science ®Google Scholar
• Zhong LP, Zhang CP, Zheng JW, et al. Increased Cyfra 21-1 concentration in saliva from primary oral squamous cell carcinoma patients. Arch Oral Biol. 2007;52:1079–1087.
   PubMed Web of Science ®Google Scholar
• Li Y, St John MA, Zhou X, et al. Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res. 2004;10:8442–8450.
   PubMed Web of Science ®Google Scholar
• Jou YJ, Lin CD, Lai CH, et al. Salivary zinc finger protein 510 peptide as a novel biomarker for detection of oral squamous cell carcinoma in early stages. Clin Chim Acta. 2011;412:1357–1365.
   PubMed Web of Science ®Google Scholar
• Stott-Miller M, Houck JR, Lohavanichbutr P, et al. Tumor and salivary matrix metalloproteinase levels are strong diagnostic markers of oral squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2011;20:2628–2636.
   PubMed Web of Science ®Google Scholar
• Franzmann EJ, Reategui EP, Pereira LH, et al. Salivary protein and solCD44 levels as a potential screening tool for early detection of head and neck squamous cell carcinoma. Head Neck. 2012;34:687–695.
   PubMed Web of Science ®Google Scholar
• St John MA, Li Y, Zhou X, et al. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2004;130:929–935.
   PubMed Web of Science ®Google Scholar
• Korostoff A, Reder L, Masood R, et al. The role of salivary cytokine biomarkers in tongue cancer invasion and mortality. Oral Oncol. 2011;47:282–287.
   PubMed Web of Science ®Google Scholar
• Arellano-Garcia ME, Hu S, Wang J, et al. Multiplexed immunobead-based assay for detection of oral cancer protein biomarkers in saliva. Oral Dis. 2008;14:705–712.
   PubMed Web of Science ®Google Scholar
• Rajkumar K, Nandhini G, Ramya R, et al. Validation of the diagnostic utility of salivary interleukin 8 in the differentiation of potentially malignant oral lesions and oral squamous cell carcinoma in a region with high endemicity. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;118:309–319.
   PubMed Web of Science ®Google Scholar
• Lisa Cheng YS, Jordan L, Gorugantula LM, et al. Salivary interleukin-6 and -8 in patients with oral cancer and patients with chronic oral inflammatory diseases. J Periodontol. 2014;85:956–965.
   PubMed Web of Science ®Google Scholar
• Kurahara S, Shinohara M, Ikebe T, et al. Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis. Head Neck. 1999;21:627–638.
   PubMed Web of Science ®Google Scholar
• Jordan RC, Macabeo-Ong M, Shiboski CH, et al. Overexpression of matrix metalloproteinase-1 and -9 mRNA is associated with progression of oral dysplasia to cancer. Clin Cancer Res. 2004;10:6460–6465.
   PubMed Web of Science ®Google Scholar
• Lallemant B, Evrard A, Combescure C, et al. Clinical relevance of nine transcriptional molecular markers for the diagnosis of head and neck squamous cell carcinoma in tissue and saliva rinse. BMC Cancer. 2009;9:370.
   PubMed Web of Science ®Google Scholar
• Hirvikoski P, Tammi R, Kumpulainen E, et al. Irregular expression of hyaluronan and its CD44 receptor is associated with metastatic phenotype in laryngeal squamous cell carcinoma. Virchows Arch. 1999;434:37–44.
   PubMed Web of Science ®Google Scholar
• Franzmann EJ, Reategui EP, Carraway KL. Salivary soluble CD44: a potential molecular marker for head and neck cancer. Cancer Epidemiol Biomarkers Prev. 2005;14:735–739.
   PubMed Web of Science ®Google Scholar
• Anderson KS, Sibani S, Wallstrom G, et al. Protein microarray signature of autoantibody biomarkers for the early detection of breast cancer. J Proteome Res. 2011;10:85–96.
   PubMed Web of Science ®Google Scholar
• Brinkmann O, Spielmann N, Wong DT. Salivary diagnostics: moving to the next level. Dent Today. 2012;31:54, 56–59. 54, 56, 7; quiz
   Google Scholar
• de Jong EP, van Riper SK, Koopmeiners JS, et al. Sample collection and handling considerations for peptidomic studies in whole saliva; implications for biomarker discovery. Clin Chim Acta. 2011;412:2284–2288.
   PubMed Web of Science ®Google Scholar
• Thomadaki K, Helmerhorst EJ, Tian N, et al. Whole-saliva proteolysis and its impact on salivary diagnostics. J Dent Res. 2011;90:1325–1330.
   PubMed Web of Science ®Google Scholar
• Schipper R, Loof A, de Groot J, et al. SELDI-TOF-MS of saliva: methodology and pre-treatment effects. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;847:45–53.
   PubMed Web of Science ®Google Scholar
• Thomadaki K, Bosch J, Oppenheim F, et al. The diagnostic potential of salivary protease activities in periodontal health and disease. Oral Dis. 2013;19:781–788.
   PubMed Web of Science ®Google Scholar
• Palanisamy V, Sharma S, Deshpande A, et al. Nanostructural and transcriptomic analyses of human saliva derived exosomes. PLoS One. 2010;5:e8577
   PubMed Web of Science ®Google Scholar
• Chiang SH, Thomas GA, Liao W, et al. RNAPro•SAL: a device for rapid and standardized collection of saliva RNA and proteins. . BioTechniques. 2015;58:69–76.
   PubMed Web of Science ®Google Scholar
• Liu CJ, Kao SY, Tu HF, et al. Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer. Oral Dis. 2010;16:360–364.
   PubMed Web of Science ®Google Scholar
• Yoshizawa JM, Wong DT. Salivary microRNAs and oral cancer detection. Methods Mol Biol. 2013;936:313–324.
   PubMedGoogle Scholar
• Scher HI, Morris MJ, Larson S, et al. Validation and clinical utility of prostate cancer biomarkers. Nat Rev Clin Oncol. 2013;10:225–234.
   PubMed Web of Science ®Google Scholar
• Jaedicke KM, Taylor JJ, Preshaw PM. Validation and quality control of ELISAs for the use with human saliva samples. J Immunol Methods. 2012;377:62–65.
   PubMed Web of Science ®Google Scholar
• Kah JC, Kho KW, Lee CG, et al. Early diagnosis of oral cancer based on the surface plasmon resonance of gold nanoparticles. Int J Nanomed. 2007;2:785–798.
   PubMed Web of Science ®Google Scholar
• Wei F, Patel P, Liao W, et al. Electrochemical sensor for multiplex biomarkers detection. Clin Cancer Res. 2009;15:4446–4452.
   PubMed Web of Science ®Google Scholar
• Malon RS, Sadir S, Balakrishnan M Saliva-based biosensors: noninvasive monitoring tool for clinical diagnostics. Biomed Res Int. 2014;2014:962903.
   PubMed Web of Science ®Google Scholar
• Tan W, Sabet L, Li Y, et al. Optical protein sensor for detecting cancer markers in saliva. Biosens Bioelectron. 2008;24:266–271.
   PubMed Web of Science ®Google Scholar